The Digital Pharma show
The Digital Pharma Show
6-7th December 2022, London. An invaluable, cost-effective gathering. Network with and learn from the UK and Europe’s leading experts who are leading the dramatic and profound digital health changes in the pharma industry.
THE DIGITAL PHARMA SHOW 2022
Tuesday 6th December 2022, London England.
Will take place within “The GIANT Health Event 2022”
"Europe's largest and most valuable international festival of health-tech innovation"
- Financial Times.
Established 9 years, GIANT Health is a vibrant, engaged UK and European business community that enables and commercializes leading health-tech innovation from across the UK and Europe.
Innovate / Collaborate / Accelerate
THE DIGITAL PHARMA SHOW 2022 will successfully bring together global Pharma corporates, tech innovators, life science and med-tech investors, established SMEs, doctors, hospital managers, government health officials, and more; to spark productive business collaboration and accelerate better health outcomes.

David Reilly
Owner
Lets Learn Digital
We work with the world’s largest brands in healthcare technology, hardware, software, Pharma, and more, to provide impactful, direct engagement with leading health-tech innovators and healthcare providers. Examples of partners include Eli Lilly, Novartis, Barclays Bank, NHS, Microsoft, Bayer, Ascensia, Cedars Sinai, and McKinsey.
Our proud partnerships with our valued partners are testimony to GIANT’s international reputation as Europe’s leading “magnet for innovation” - BBC in the health sector.
Sponsors & exhibitors can build cost-effective sales, new business development, and marketing communication / brand-building programs on the foundation of the GIANT Health Event, accessing GIANT’s UK and European community of nearly 300,000 passionate healthcare innovators.
time |
Session title |
Session description |
10:00 - 11:30 |
Digital Therapeutics (DTx) |
Covid-19 has drastically accelerated the adoption of digital health solutions. The increased utilization of digital therapeutics has shown to ease the burden faced by the healthcare system during the pandemic. This shift towards digital adoption has put pressure on pharma to innovate beyond their traditional approaches. 1. What should DTx/Pharma companies look for when establishing partnerships? |
11:30 - 13:00 |
Real World Evidence |
With the exponentially increasing array of data generated outside of classic clinical trials, the evidence we can gleam from them is playing an increasingly important role in all areas of the healthcare value chain. Efficient use of these real world evidence (RWE) is seen by many leaders as the next huge step in medical product development and validation. Whilst definitely not without possible concerns, RWE presents countless benefits over randomised controlled trials and are particularly useful in guiding healthcare decision making. Only by learning from real life scenarios can we accurately evaluate how effective anything truly is. |
13:00 - 14:30 |
Decentralised virtual Clinical Trials |
The pandemic has accelerated the rate at which real-world data and digital tools have been adopted to conduct clinical trials. The pandemic coupled with the appropriate technologies have caused a fundamental shift towards decentralized virtual clinical trials. Resulting in rich data sets invaluable for researching a wide range of interventions, variables, and specific patient populations. 1. What are the differences between traditional and virtual clinical trials? |
Transforming healthcare through AI drug discovery |
Many vibrant new companies challenge the traditional drug discovery methods of ‘Big Pharma’ by harnessing the power of computers and AI. But is it the case that for much 'AI' drug discovery, the data has already been processed by traditional pharmaceutical companies? Learn in this module about how AI drug design is changing the paradigm of drug discovery |
|
15:30 - 17:30 |
How global Pharma companies can adapt digital innovations to maximise success |
Addressing the digital skills and innovation gap needed for global Pharma businesses - Fully immersive and engaged learning |
We are dedicating this module to the innovative and forward thinking leaders from the Pharma industry, academia, and regulatory bodies, involved in any area of the digital healthcare value chain.
If you are interested in building cross-stakeholder partnerships and learning more about digital innovation in the Pharma sector, this conference is for you.
Innovate / Collaborate / Accelerate
We successfully bring together tech innovators, investors, global Pharma corporates, established SMEs, doctors, hospital managers, government health officials, and more; to spark productive business collaboration and accelerate better health outcomes.
Attend to meet with the world’s largest brands in healthcare technology, hardware, software, Pharma, and more, to gain direct engagement with leading health-tech innovators and healthcare providers.
Sponsors & exhibitors can build cost-effective sales, new business development, and marketing communication programmes on the foundation of the THE DIGITAL PHARMA Show 2022, at the GIANT Health Event, accessing GIANT’s UK and European community of nearly 300,000 passionate healthcare innovators.
